- Report
- November 2021
- 1112 Pages
Global
From €5275EUR$6,000USD£4,546GBP
- Report
- November 2021
- 527 Pages
Global
From €3517EUR$4,000USD£3,030GBP
- Report
- November 2021
- 545 Pages
Global
From €3517EUR$4,000USD£3,030GBP
- Report
- November 2021
- 233 Pages
Global
From €2198EUR$2,500USD£1,894GBP
- Report
- November 2021
- 802 Pages
Global
From €4396EUR$5,000USD£3,788GBP
- Report
- November 2021
- 1184 Pages
Global
From €5275EUR$6,000USD£4,546GBP
- Report
- November 2021
- 1165 Pages
Global
From €5275EUR$6,000USD£4,546GBP
- Book
- May 2025
- 384 Pages
- Book
- January 2024
- 496 Pages
- Book
- March 2022
- 896 Pages
- Book
- December 2020
- 432 Pages
- Book
- October 2020
- 288 Pages
- Book
- October 2020
- 640 Pages
- Book
- August 2015
- 648 Pages
- Book
- July 2011
- 800 Pages

The Polymerase Chain Reaction (PCR) market is a subset of the genomics industry. It is a technology used to amplify and replicate DNA sequences, allowing for the detection and analysis of genetic material. PCR is used in a variety of applications, including diagnostics, forensics, and research. It is a key tool in the development of personalized medicine, as it allows for the detection of genetic mutations and other biomarkers. PCR is also used in the development of gene therapies, as it allows for the insertion of new genetic material into cells.
The PCR market is highly competitive, with a number of companies offering products and services. These include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, QIAGEN, and Roche. Show Less Read more